Recursion adds new chemical entity targeting fibrotic diseases
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that…
Lire la suite / Read more